For more information

on this study please

call +1 877-379-3718

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.

Study ID

104154

Study Title Open, prospective study of the safety of GSK Biologicals' Boostrix® (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed) administered to a cohort of adolescents in a US Health Maintenance Organization (HMO)
Clinicaltrials.gov Identifier NCT00297856
Sponsor GlaxoSmithKline
Collaborators N/A
Study Recruitment Status Completed
Generic Name Combined Reduced Antigen Content Diphtheria, Tetanus, Acellular Pertussis Vaccine
Trade Name Boostrix
Study Indication Diphtheria; Tetanus; acellular pertussis